Neha Vapiwala, MD
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: September 27, 2005
Dec 17, 2010 - A combination therapy of immune stimulants and regulatory molecules appears to block angiogenesis critical to tumor development, according to research published in the Dec. 15 issue of Cancer Research.
Oct 28, 2010